Dick Pluim

5.2k total citations · 1 hit paper
70 papers, 4.2k citations indexed

About

Dick Pluim is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dick Pluim has authored 70 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 29 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dick Pluim's work include Cancer therapeutics and mechanisms (16 papers), Drug Transport and Resistance Mechanisms (14 papers) and Colorectal Cancer Treatments and Studies (12 papers). Dick Pluim is often cited by papers focused on Cancer therapeutics and mechanisms (16 papers), Drug Transport and Resistance Mechanisms (14 papers) and Colorectal Cancer Treatments and Studies (12 papers). Dick Pluim collaborates with scholars based in Netherlands, United States and United Kingdom. Dick Pluim's co-authors include Jan H.M. Schellens, Jos H. Beijnen, Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Marc Maliepaard, Olaf van Tellingen, Pauline Breedveld, Robert C.A.M. van Waardenburg, Matthijs M. Tibben and Alfred H. Schinkel and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Dick Pluim

70 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

2004 760 citations Dick Pluim, Jos H. Beijnen et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Dick Pluim

Since Specialization

Citations

This map shows the geographic impact of Dick Pluim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick Pluim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick Pluim more than expected).

Fields of papers citing papers by Dick Pluim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick Pluim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick Pluim. The network helps show where Dick Pluim may publish in the future.

Co-authorship network of co-authors of Dick Pluim

This figure shows the co-authorship network connecting the top 25 collaborators of Dick Pluim. A scholar is included among the top collaborators of Dick Pluim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dick Pluim. Dick Pluim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid 2025 ·European Journal of Cancer ·(unknown), Dieta Brandsma, Els Verhoeven, (unknown), Kim Monkhorst, Adrianus J. de Langen, (unknown), Dick Pluim, Tom van Wezel, (unknown), Mirjam C. Boelens	1
2	High accumulation of nivolumab in human breast milk: A case report 2023 ·Biomedicine & Pharmacotherapy ·Karen de Jong, (unknown), Dick Pluim, Hilde Rosing, Jos H. Beijnen, (unknown), Thomas P. C. Dorlo, Alwin D. R. Huitema, Frédéric Amant	2
3	Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab 2023 ·New England Journal of Medicine ·Manuel A. Baarslag, Joosje H. Heimovaara, Jessica S.W. Borgers, Koen van Aerde, Hans J. P. M. Koenen, Ruben L. Smeets, (unknown), Dick Pluim, Shoko Vos, Stefanie Henriet, Jan Willem B. de Groot, Martine van Grotel, Hilde Rosing, Jos H. Beijnen, Alwin D. R. Huitema, John B.A.G. Haanen, Frédéric Amant, (unknown)	14
4	Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir 2021 ·The Pharmacogenomics Journal ·(unknown), Dick Pluim, Thomas P. C. Dorlo, Serena Marchetti, Alwin D. R. Huitema, Jos H. Beijnen	1
5	Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer 2020 ·Clinical Cancer Research ·(unknown), Michel M. van den Heuvel, Judi van Diessen, Heike Peulen, Erik van Werkhoven, Adrianus J. de Langen, Ferry Lalezari, Dick Pluim, Manon Verwijs-Janssen, Conchita Vens, Jan H.M. Schellens, Neeltje Steeghs, Marcel Verheij, Baukelien van Triest	39
6	Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases 2020 ·Neurology ·Mark T. J. van Bussel, Dick Pluim, Bojana Milojkovic Kerklaan, Mijke Bol, Karolina Sikorska, (unknown), Daan van den Broek, Jos H. Beijnen, Jan H.M. Schellens, Dieta Brandsma	51
7	Phase I pharmacological study of continuous chronomodulated capecitabine treatment 2020 ·Pharmaceutical Research ·(unknown), Bart Jacobs, Dick Pluim, Hilde Rosing, Niels de Vries, Erik van Werkhoven, Bastiaan Nuijen, Jos H. Beijnen, Alwin D. R. Huitema, Jan H.M. Schellens, Serena Marchetti	13
8	Phase I pharmacological study of continuous chronomodulated capecitabine treatment 2018 ·Annals of Oncology ·(unknown), Bart Jacobs, Dick Pluim, Hilde Rosing, Bastiaan Nuijen, Jos H. Beijnen, Alwin D. R. Huitema, Jan H.M. Schellens, Silvia Marchetti	1
9	Dihydrofolate Reductase/Thymidylate Synthase Fine-Tunes the Folate Status and Controls Redox Homeostasis in Plants 2017 ·The Plant Cell ·Vera Gorelova, (unknown), Jeroen Van Daele, Dick Pluim, Coline Meï, Ann Cuypers, Olivier Leroux, Fabrice Rébeillé, Jan H.M. Schellens, Dieter Blancquaert, Christophe P. Stove, Dominique Van Der Straeten	68
10	A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine 2016 ·Cancer Chemotherapy and Pharmacology ·Bart Jacobs, (unknown), Hilde Rosing, Dick Pluim, Matthijs M. Tibben, Niels de Vries, Bastiaan Nuijen, Alwin D. R. Huitema, Jos H. Beijnen, Jan H.M. Schellens, Serena Marchetti	4
11	“Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183” 2014 ·Investigational New Drugs ·Serena Marchetti, Dick Pluim, Jos H. Beijnen, Roberto Mazzanti, Olaf van Tellingen, Jan H.M. Schellens	9
12	Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues 2013 ·Clinical Cancer Research ·Fan Lin, Serena Marchetti, Dick Pluim, Dilek Iusuf, Roberto Mazzanti, Jan H.M. Schellens, Jos H. Beijnen, Olaf van Tellingen	38
13	Pharmacodynamic assay of thymidylate synthase activity in peripheral blood mononuclear cells 2013 ·Analytical and Bioanalytical Chemistry ·Dick Pluim, (unknown), Bart Jacobs, (unknown), Jos H. Beijnen, Jan H.M. Schellens	6
14	Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular‐signal‐regulated kinase and DNA in circulating tumor cells 2012 ·Cytometry Part A ·Dick Pluim, Lot A. Devriese, Jos H. Beijnen, Jan H.M. Schellens	24
15	Phase I Pharmacokinetic and Pharmacodynamic Study of Carboplatin and Topotecan Administered Intravenously Every 28 Days to Patients with Malignant Solid Tumors 2009 ·Clinical Cancer Research ·David S. Boss, (unknown), (unknown), Dick Pluim, Hilde Rosing, W.W. ten Bokkel Huinink, Jos H. Beijnen, Jan H.M. Schellens	1
16	Extensive Metabolism and Hepatic Accumulation of Gemcitabine After Multiple Oral and Intravenous Administration in Mice 2008 ·Drug Metabolism and Disposition ·Stephan A. Veltkamp, Dick Pluim, Olaf van Tellingen, Jos H. Beijnen, Jan H.M. Schellens	25
17	Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin 2008 ·Analytical and Bioanalytical Chemistry ·E. E. M. Brouwers, Matthijs M. Tibben, Dick Pluim, Hilde Rosing, Henk Boot, Annemieke Cats, Jan H.M. Schellens, Jos H. Beijnen	33
18	Platinated DNA Adducts Enhance Poisoning of DNA Topoisomerase I by Camptothecin 2004 ·Journal of Biological Chemistry ·Robert C.A.M. van Waardenburg, (unknown), Maria A.J. van Eijndhoven, C. Verseyden, Dick Pluim, Lars E.T. Jansen, Mary‐Ann Bjornsti, Jan H.M. Schellens	36
19	32P-Postlabeling Assay for the Quantification of the Major Platinum-DNA Adducts 1999 ·Analytical Biochemistry ·Dick Pluim, Marc Maliepaard, Robert C.A.M. van Waardenburg, Jos H. Beijnen, Jan H.M. Schellens	41
20	In vitro antagonistic cytotoxic interactions between platinum drugs and taxanes on bone marrow progenitor cell CFU-GM 1999 ·Anti-Cancer Drugs ·(unknown), Marc Maliepaard, Dick Pluim, (unknown), I. C. M. Slaper-Cortenbach, Jan H.M. Schellens	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact